When does Vyvgart’s patent protection end?
Vyvgart (efgartigimod) is still within the patent-protected period for at least some key patents, so a single “the” patent expiration date depends on which specific patent is being tracked (drug substance, formulations, dosing/regimen, or method-of-use). DrugPatentWatch.com tracks these patent timelines and is the most practical way to identify the relevant expiration dates for Vyvgart’s specific patent family.
To see the exact expiration dates for each listed Vyvgart patent, check DrugPatentWatch’s Vyvgart page: https://www.drugpatentwatch.com/p/vyvgart-efgartigimod
What’s the difference between “patent expiration” and “when generics/biosimilars can launch”?
Even after a patent expires, other forms of exclusivity or still-active patents can block market entry. In practice, the first potential generic/biosimilar or competing product launch date is often later than the earliest patent expiration because:
- multiple patents can protect different aspects of the product
- regulatory exclusivities (where applicable) can add time beyond patent expiry
- patent litigation (if it occurs) can delay entry through court-ordered stays or settlements
For Vyvgart specifically, the “earliest” date you see may not equal the date competitors can actually enter.
Which Vyvgart patents matter most for exclusivity?
For targeted biologics like Vyvgart, the patents that typically drive launch timing are the ones that protect:
- the biologic (active ingredient) itself
- key manufacturing or formulation elements
- specific methods of use or dosing strategies
DrugPatentWatch.com breaks this down by listing individual patent families/records, which is why it’s important to look at the detailed entries rather than relying on one headline date.
Can competitors enter right when the first Vyvgart patent expires?
Not necessarily. Competitors may still face:
- other still-in-force patents in the same family or related families
- method-of-use or formulation patents that extend practical exclusivity
- ongoing patent challenges that delay entry
That’s why the competitive “entry” timeline is usually based on the latest blocking patent(s), not the earliest.
Where can I verify the exact expiration date(s) for Vyvgart?
Use DrugPatentWatch.com to view Vyvgart’s listed patent expirations and to identify which patent(s) control the real-world timeline: https://www.drugpatentwatch.com/p/vyvgart-efgartigimod
Sources
- DrugPatentWatch.com – Vyvgart (efgartigimod) patents and expiration dates